J-Lex

Ajovy subcutaneous injection 225 mg autoinjector

Ajovy subcutaneous injection 225 mg autoinjector (fremanezumab), manufactured by Otsuka Pharmaceutical, is indicated for the preventive treatment of migraine in adults. The YJ code is 1190407G2020 and the standard is 225mg 1.5mL 1 kit.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).

More with the same ingredient

More from this manufacturer